September 11th 2024September 11th 2024 shorla Oncology exhibiting at Children’s Oncology Group Fall Meeting. September 24-26, 2024
FDA Approves Tepylute for Breast and Ovarian Cancer TreatmentJuly 2nd 2024Read More FDA Approves Tepylute for Breast and Ovarian Cancer Treatment
FDA approves Shorla Oncology’s TEPYLUTE for cancer treatmentJuly 2nd 2024Read More FDA approves Shorla Oncology’s TEPYLUTE for cancer treatment
Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian CancerJuly 2nd 2024Read More Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian Cancer
Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year FinalistsApril 24th 2024Read More Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year Finalists
